More articles from Volume 49, Issue 1, 2020
Relationship between ACR and other determinants of microalbuminuria in T2DM patients
Uticaj porođajne mase i aktuelne težine deteta na nastanak prevremenog puberteta
Frequency and histological-cytological correlation of premalignant and malignant changes in the cervix in women of different ages
Errors and artifacts on radiographs
Strategije suočavanja sa anksioznošću u situaciji testiranja engleskog jezika kod studenata visokog i niskog samopoštovanja
Relationship between ACR and other determinants of microalbuminuria in T2DM patients
,
Dijana Mirić
,
Bojana Kisić
,
Dragana Puhalo-Sladoje
,
Bratislav Mirić
,
Dragiša Rašić
,
Ilija Dragojević
Dragana Pavlović
Abstract
References
1.
Toyama T, Furuichi K, Ninomiya T, Shimizu M, Hara A, Iwata Y, et al. The impacts of albuminuria and low eGFR on the risk of cardiovascular death, all-cause mortality, and renal events in diabetic patients: Meta-analysis. Vol. 8. 2013. p. 71810.
2.
Bakker AJ, Bierma-Ram A, Keidel H, Syperda H, Zijlstra A. Micro)Albuminuria: antigen excess detection in the Roche modular analyzer. Vol. 51. 2005. p. 1071.
3.
Lj Đ, B AM, M A, J B, Z V, B G, et al. Epidemiology of end-stage renal disease and hemodialysis treatment in Serbia at the turn of the millennium. Vol. 16. 2012. p. 517–25.
4.
Dragovic T. Microalbuminuria in diabetes: definition, identification techniques, and the significance of early recognition. Vol. 63. 2006. p. 1027–32.
5.
Sugawara A, Kawai K, Motohashi S, Saito K, Kodama S, Yachi Y, et al. HbA1c variability and the development of microalbuminuria in type 2 diabetes: Tsukuba Kawai Diabetes Registry 2. Vol. 55. 2012. p. 2128–31.
6.
Levin A, Stevens PE, Bilous RW, Coresh J, Francisco ALM, Jong PE, et al. Kidney disease: Improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Vol. 3. 2013. p. 1–150.
7.
Donadio C, Lucchesi A, Ardini M, Cystatin GR, C. b2-microglobulin, and retinol-binding protein as indicators of glomerular filtration rate: comparison with plasma creatinine. Vol. 24. 2001. p. 835–42.
8.
Johns KW, Robinson CE, Wilson IM, Billington EO, Bondy GP, Tildesley HD. Does albumin:creatinine ratio lack clinical utility in predicting microalbuminuria? Vol. 48. 2006. p. 399–403.
9.
Lemley KV, Abdullah I, Myers BD, Meyer TW, Blouch K, Smith WE, et al. Evolution of incipient nephropathy in type 2 diabetes mellitus. Vol. 58. 2000. p. 1228–37.
10.
Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. In p. 461–70.
11.
Basi S, Mimran A, Fesler P, Lewis JB. Microalbuminuria in Type 2 diabetes and hypertension. Vol. 31. 2008. p. 194–201.
12.
Lee IT, Wang CY, Huang CN, Fu CC, Sheu WHH. High triglyceride-to-HDL cholesterol ratio associated with albuminuria in type 2 diabetic subjects. Vol. 27. 2013. p. 243–7.
13.
Grujić V, Dragnić N, Radić I, Harhaji S, Šušnjević S. Overweight and Obesity among adults in Serbia: Results from the National Health Survey. Vol. 15, Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity. 2010. p. e34–42.
14.
Grujic V, Dragnic N, Kvrgic S, Susnjevic S, Grujic J, Travar S. Epidemiology of hypertension in Serbia: Results of national survey. Vol. 22. 2012. p. 261–6.
15.
Registry SD. Incidence and mortality of diabetes in Serbia 2012. Vol. N0. 2012. p. 7.
16.
Dobiasova M, Frohlich J. The plasma parameter log(TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FERHDL. Vol. 34. 2001. p. 583–8.
17.
Kanellis J, Kang DH. Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease. Vol. 25. 2005. p. 39–42.
18.
Fanali G, Masi A, Trezza V, Marino M, Fasano M, Ascenzi P. Human serum albumin: from bench to bedside. Vol. 33. 2012. p. 209–90.
19.
Nathan DN, McGee P, Steffes MW, Machin JM, Group DCCT /E. DICR. Relationship of glycated albumin to blood glucose and HbA1c values and to retinopathy, nephropathy, and cardiovascular outcomes in the DCCT/EDIC Study. Vol. 63. 2014. p. 282–90.
20.
Iglesias J, Levine JS. Albuminuria and renal injury - beware of proteins bearing gifts. Vol. 16. 2001. p. 215–8.
21.
Márquez E, Riera M, Pascual J, Soler MJ. Albumin inhibits the insulin-mediated ACE2 increase in cultured podocytes. Vol. 306, American Journal of Physiology-Renal Physiology. 2014. p. F1327–34.
22.
Timmeren MM, ML G, W H, PA K, Goor H, CA S, et al. Oleic acid loading does not add to the nephrotoxic effect of albumin in an amphibian and chronic rat model of kidney injury. Vol. 23. 2008. p. 3814–23.
23.
Gross ML, Piecha G, Bierhaus A, Hanke W, Henle T, Schirmacher P, et al. Glycated and carbamylated albumin are more “nephrotoxic” than unmodified albumin in the amphibian kidney. Vol. 301:F476-F485. 2011.
24.
Tabaei BP, Al-Kassab AS, Ilag LL, Zawacki CM, Herma WH. Does microalbuminuria predict diabetic nephropathy? Vol. 24. 2001. p. 1560–6.
25.
Chuengsamarn S, Rattanamongkolgul S, Jirawatnotai S. Association between serum uric acid level and microalbuminuria to chronic vascular complications in Thai patients with type 2 diabetes. Vol. 28, Journal of Diabetes and its Complications. 2014. p. 124–9.
26.
Fukui M, Tanaka M, Shiraishi E, Harusato I, Hosoda H, Asano M, et al. Serum uric acid is associated with microalbuminuria and subclinical atherosclerosis in men with type 2 diabetes mellitus. Vol. 57, Metabolism. 2008. p. 625–9.
27.
Kim WJ, Kim SS, Bae MJ, Yi YS, Jeon YK, Kim BH, et al. High-normal serum uric acid predicts the development of chronic kidney disease in patients with type 2 diabetes mellitus and preserved kidney function. Vol. 28, Journal of Diabetes and its Complications. 2014. p. 130–4.
28.
Amann B, Tinzmann R, Angelkort B. ACE inhibitors improve diabetic nephropathy through suppression of renal MCP-1. Vol. 26. 2003. p. 2421–5.
29.
Tojo A, Onozato ML, Kirahara H, Sakai T, Goto A, Fujita T. Angiotensin II blockade restores albumin reabsorption in the proximal tubules of diabetic rats. Vol. 26. 2003. p. 413–9.
30.
Zhu XW, Deng FY, Lei SF. Meta-analysis of Atherogenic Index of Plasma and other lipid parameters in relation to risk of type 2 diabetes mellitus. Vol. 9. 2015. p. 60–7.
31.
Mattix HJ, Hsu C yuan, Shaykevich S, Curhan G. Use of the Albumin/Creatinine Ratio to Detect Microalbuminuria. Vol. 13, Journal of the American Society of Nephrology. 2002. p. 1034–9.
32.
Moura RSSS, Vasconcelos DF, Frietas E, Moura FJD, Rosa TT, Cystatin VJPR, et al. Log TG/HDLc and metabolic syndrome are associated with microalbuminuria in hypertension. Vol. 102. 2014. p. 54–9.
33.
Tseng CH. Differential dyslipidemia associated with albuminuria in type 2 diabetic patients in Taiwan. Vol. 42. 2009. p. 1024.
34.
MacIsaac RJ, Tsalamandris C, Panagiotopoulos S, Smith TJ, McNeil KJ, Jerumes H. Nonalbuminuric renal insufficiency in type 2 diabetes. Vol. 27. 2004. p. 195–200.
35.
The synergistic relationship between estimated GFR and microalbuminuria in predicting long-term progression to ESRD or death in patients with diabetes: results from the Kidney Early Evaluation Program (KEEP. Vol. 61. 2013. p. 12–23.
36.
Chida S, Fujita Y, Ogawa A. Levels of albuminuria and risk of developing macroalbuminuria in type 2 diabetes: historical cohort study. Vol. 6. 2016. p. 26380.
Citation
Copyright
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Article metrics
Google scholar:
See link
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
